Publications by authors named "Talukder R"

Background: FGFR2/3, MTAP and ERBB2 genomic alterations have treatment targets in advanced urothelial carcinoma (aUC). These alterations may affect tumor microenvironment and outcomes with immune checkpoint inhibitors (ICIs) in aUC.

Patients And Methods: We identified patients with available genomic data in our multi-institution cohort of patients with aUC treated with ICI.

View Article and Find Full Text PDF

Enfortumab vedotin (EV) is used as monotherapy or combined with pembrolizumab in advanced urothelial carcinoma (aUC), but biomarker data associated with EV outcomes are limited. We identified 170 patients in the UNITE study who received EV monotherapy and had molecular biomarker data available. Outcomes for groups with and without a particular biomarker were compared using logistic regression (unadjusted) for the objective response rate (ORR), and a log-rank test and Cox proportional-hazard models (CPHMs) for progression-free survival (PFS) and overall survival (OS) from EV initiation.

View Article and Find Full Text PDF

Background: Anti-PD-(L)1 agent are approved as first- and second-line treatment options in advanced urothelial cancer (UC), but information about long-term survival is scarce. There is a need for prognostic factors, as these may help in the decision-making concerning anti-PD-(L)1 in patients with UC. Here, we examined long-term survival following anti-PD-(L)1 in advanced UC and assessed clinical factors for their correlation with survival.

View Article and Find Full Text PDF

Anestrus poses substantial challenges for dairy industries worldwide. This research aims to evaluate the effect of oral supplementation with garlic alone, vitamins A, D, E alone, and their combination on heat detection, pregnancy rate and serum profile in anestrus dairy cows. Using a completely randomized design, this study, conducted over 327 days, evaluated 72 anestrus-affected cows, which were divided into four groups.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the relationship between Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) status in patients with urothelial carcinoma (UC) receiving immune checkpoint inhibitors (ICI), focusing on overall survival (OS).
  • - Results showed that patients with a higher TMB (≥10 mut/Mb) generally experienced longer median OS compared to those with lower TMB, although these differences weren't always statistically significant.
  • - Notably, patients treated with maintenance avelumab had a significantly better OS when TMB was high (61 months vs. 17 months for low TMB), indicating potential benefits of ICI based on TMB and MSI status, warranting further investigation.
View Article and Find Full Text PDF
Article Synopsis
  • - The study examines genomic alterations (GA) in patients with urothelial bladder cancer (UBC), focusing on those with ERBB2 mutations and amplifications, and comparing them to patients with wild-type ERBB2.
  • - Findings show that 6.3% of UBC cases have short variant GAs in the ERBB2 extracellular domain, 2.7% in the kinase domain, and 9.1% show ERBB2 amplification, while 81.9% are ERBB2 wild-type.
  • - The analysis indicates that ERBB2-altered cases exhibit higher tumor mutational burden and specific genetic changes compared to wild-type ERBB2 cases, with notable associations found between various genetic markers
View Article and Find Full Text PDF

Background: Platinum-based chemotherapy (PBC) followed by avelumab switch maintenance in nonprogressors is standard first line (1L) treatment for advanced urothelial carcinoma (aUC). We describe clinical features and outcomes in a "real-world' cohort treated with avelumab maintenance for aUC.

Materials And Methods: This was a retrospective cohort study of patients (pts) who received 1L switch maintenance avelumab after no progression on PBC for aUC.

View Article and Find Full Text PDF

Background: Immune-related hepatitis (irH) is a serious immune-related adverse event (IRAE) that may result in morbidity, immune checkpoint inhibitor (ICI) therapy interruption and, rarely, mortality. The impact of underlying liver pathology, including liver metastasis, on the incidence of irH remains poorly understood.

Objectives: We hypothesized that the presence of underlying liver pathology increased the risk of irH in patients with cancer treated with ICI.

View Article and Find Full Text PDF

Background: Management of immune-related adverse events (irAEs) is important as they cause treatment interruption or discontinuation, more often seen with combination immune checkpoint inhibitor (ICI) therapy. Here, we retrospectively evaluated the safety and effectiveness of anti-interleukin-6 receptor (anti-IL-6R) as therapy for irAEs.

Methods: We performed a retrospective multicenter study evaluating patients diagnosed with de novo irAEs or flare of pre-existing autoimmune disease following ICI and were treated with anti-IL-6R.

View Article and Find Full Text PDF

A wide-field surface plasmon resonance (SPR) microscopy sensor employs the surface plasmon resonance phenomenon to detect individual biological and non-biological nanoparticles. This sensor enables the detection, sizing, and quantification of biological nanoparticles (bioNPs), such as extracellular vesicles (EVs), viruses, and virus-like particles. The selectivity of bioNP detection does not require biological particle labeling, and it is achieved via the functionalization of the gold sensor surface by target-bioNP-specific antibodies.

View Article and Find Full Text PDF

Fixed drug eruption (FDE) is a distinctive pattern of cutaneous adverse drug reaction. Characteristically the eruption recurs at the same site on re exposure to the offending agent. Aim of this study was to evaluate and identification of the various offending drugs causing FDE which may help the physician to limit the associate complication regarding the drug.

View Article and Find Full Text PDF

Objectives: To examine patient and disease characteristics, toxicity, and clinical outcomes for patients with advanced urothelial carcinoma (aUC) who are rechallenged with immune checkpoint inhibitor (ICI)-based therapy.

Patients And Methods: In this retrospective cohort, we included patients treated with ICI for aUC after having prior ICI treatment. Endpoints included the evaluation of radiographic response and disease control rates with first and second ICI courses, outcomes based on whether there was a change in ICI class (anti-PD-1 vs.

View Article and Find Full Text PDF

Installation of a biogas plant in a rural region has become a viable alternative energy source with a variety of health and environmental advantages. Though Bangladesh has enormous resources for biogas production, biogas energy production is infancy stage in Bangladesh. The study aims to explore the economic aspect of household-level biogas plants and determine the relationship between biogas plant functionality and different factors.

View Article and Find Full Text PDF

Background: Early progression on first-line (1L) platinum-based therapy or between therapy lines may be a surrogate of more aggressive disease and poor outcomes in advanced urothelial carcinoma (aUC), but its prognostic role regarding immune checkpoint inhibitor (ICI) response and survival is unclear. We hypothesized that shorter time until start of second-line (2L) ICI would be associated with worse outcomes in aUC.

Patients And Methods: We performed a retrospective multi-institution cohort study in patients with aUC treated with 1L platinum-based chemotherapy, who received 2L ICI.

View Article and Find Full Text PDF

Background: Sites of metastasis have prognostic significance in advanced urothelial carcinoma (aUC), but more information is needed regarding outcomes based on metastatic sites in patients treated with immune checkpoint inhibitors (ICI). We hypothesized that presence of liver/bone metastases would be associated with worse outcomes with ICI.

Methods: We identified a retrospective cohort of patients with aUC across 26 institutions, collecting demographics, clinicopathological, treatment, and outcomes information.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICI) improve overall survival (OS) in patients with locally advanced, unresectable, or metastatic urothelial carcinoma (aUC), but response rates can be modest. We compared outcomes between patients with and without prior intravesical Bacillus Calmette-Guerin (BCG), who received ICI for aUC, hypothesizing that prior intravesical BCG would be associated with worse outcomes.

Patients And Methods: We performed a retrospective cohort study across 25 institutions in US and Europe.

View Article and Find Full Text PDF
Article Synopsis
  • - This study analyzes the efficacy of enfortumab vedotin (EV) for treating advanced urothelial cancer (aUC) in patients not previously well represented in clinical trials, focusing on real-world experiences from a retrospective study called UNITE.
  • - The results from 304 patients indicated a 52% overall response rate to EV monotherapy, with similar responses in various patient subsets, including those with significant comorbidities that were often excluded from clinical trials.
  • - Overall survival was about 14.4 months, showing that EV can be effective even for patients with variant histology or specific genetic alterations, aligning with earlier clinical trial findings.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to compare the clinical outcomes of advanced urothelial carcinoma patients treated with immune checkpoint inhibitors, focusing on those who had prior radical surgery or radiation therapy versus those who did not.
  • Researchers analyzed data from 562 patients across multiple institutions, assessing response rates, progression-free survival, and overall survival based on prior treatments.
  • Results showed that patients in the second-plus-line treatment group with previous radical surgery had significantly better outcomes compared to those without, but this difference was not observed in the first-line setting.
View Article and Find Full Text PDF

Background: We report a patient with Essential Thrombocythemia (ET), subsequently diagnosed with concurrent myeloid and lymphoid leukemia. Generally, the molecular mechanisms underlying leukemic transformation of Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are poorly understood. Risk of transformation to acute myelogenous leukemia (AML) is low; transformation to both AML and acute lymphoblastic leukemia (ALL) is extremely low.

View Article and Find Full Text PDF

Caesarean section (CS) is the most frequently performed major operation in obstetrics. Its frequency is gradually increasing because of extended indications. Now-a-days, caesarean section is also being performed at patient's request in absence of a medical indication.

View Article and Find Full Text PDF

The recurrent appearance of novel coronaviruses (CoVs) and the mortality and morbidity caused by their outbreaks aroused a widespread response among the global science community. Wild birds' high biodiversity, perching and migratory activity, ability to travel long distances and possession of a special adaptive immune system may make them alarming sources of zoonotic CoV-spreading vectors. This review gathers the available evidence on the global spread of CoVs in wild birds to date.

View Article and Find Full Text PDF

Introduction: Pharmacy faculty understanding of the scholarship of teaching and learning (SoTL) and its recognition remain unclear. This study aimed to determine faculty SoTL perceptions and whether it should be recognized in promotion and tenure decisions.

Methods: A survey instrument was developed and distributed to 6454 faculty in 139 United States pharmacy programs.

View Article and Find Full Text PDF

Using a bibliometric method, this study assessed global educational research output on interprofessional education (IPE) and contributions from pharmacy relative to other healthcare academic programs, such as nursing, over the last 20 years. The Web of Science database was searched for articles published between 1998 and 2018. In addition, PubMed and the journals the American Journal of Pharmaceutical Education, Currents in Pharmacy Teaching and Learning, and INNOVATIONS in pharmacy were searched.

View Article and Find Full Text PDF

Stroke is one of the leading cause of disability worldwide. Motor function deficits due to stroke contribute to overall low quality of life. The objective was of this study is to observe functional motor outcome after stroke with low dose Levodopa therapy.

View Article and Find Full Text PDF